COMP <GO>
UFPT vs LMAT // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
UFP Technologies Inc. (NASDAQ) VS. LeMaitre Vascular Inc. (NASDAQ) • 15-METRIC TALLY: UFPT 6
— LMAT 7
■ METRIC PARITY
LAST: $283.97 (-0.19%) • MKT CAP: $2.20B
options-implied-move
—
LAST: $81.26 (+0.40%) • MKT CAP: $1.85B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UFPT VS. LMAT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UFPT | LMAT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.30% | 71.50% | -43.20 | LMAT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.90% | 14.70% | -0.80 | LMAT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.7x | 28.3x | -2.60 | UFPT | /valuation <GO> |
| Free Cash Flow Yield | 4.05% | 4.17% | -0.12 | LMAT | /fcf-yield <GO> |
| Operating Margin | 15.30% | 27.20% | -11.90 | LMAT | /operating-margins <GO> |
| Net Profit Margin | 11.30% | 23.10% | -11.80 | LMAT | /net-margins <GO> |
| Revenue Growth (YoY) | 19.50% | 13.50% | +6.00 | UFPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.93% | -0.93 | LMAT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.31 | 7.30 | +1.01 | UFPT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | UFPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.0 | 46.3 | -1.30 | LMAT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.0x | 28.4x | -0.40 | UFPT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.20B | $1.85B | $352.6M | UFPT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UFPT REV | LMAT REV | UFPT GROSS % | LMAT GROSS % | UFPT FCF | LMAT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $602.8M | $249.6M | 28.3% | 71.5% | $91.9M | $81.3M |
| FY 2024 | $504.4M | $219.9M | 29.1% | 68.6% | $56.9M | $44.1M |
| FY 2023 | $400.1M | $193.5M | — | — | $41.3M | $36.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UFPT // BETA —
LMAT // BETA —